Doxil and Neuropathy peripheral - a phase IV clinical study of FDA data
Neuropathy peripheral is found among people who take Doxil, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Doxil and have Neuropathy peripheral. It is created by eHealthMe based on reports of 10,200 people who have side effects when taking Doxil from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
10,200 people reported to have side effects when taking Doxil.
Among them, 318 people (3.12%) have Neuropathy peripheral.
What is Doxil?
Doxil has active ingredients of doxorubicin hydrochloride. It is often used in ovarian cancer. eHealthMe is studying from 10,253 Doxil users for its effectiveness, alternative drugs and more.
What is Neuropathy peripheral?
Neuropathy peripheral (surface nerve damage) is found to be associated with 2,666 drugs and 1,960 conditions by eHealthMe.
Number of Doxil and Neuropathy peripheral reports submitted per year:
Time on Doxil when people have Neuropathy peripheral *:
Gender of people who have Neuropathy peripheral when taking Doxil*:
Age of people who have Neuropathy peripheral when taking Doxil *:
Common drugs people take besides Doxil *:
Common side effects people have besides Neuropathy peripheral *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Doxil and have Neuropathy peripheral?Check whether Neuropathy peripheral is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Neuropathy peripheral and when was it recovered:
Expand to all the drugs that have ingredients of doxorubicin hydrochloride:
Alternative drugs to, pros and cons of Doxil:
- Doxil (10,253 reports)
Common Doxil side effects:
- Hair loss: 2,315 reports
- Fatigue (feeling of tiredness): 574 reports
- Pain: 568 reports
- Thrombocytopenia (decrease of platelets in blood): 551 reports
- Weakness: 516 reports
- Fever: 513 reports
Browse all side effects of Doxil:a b c d e f g h i j k l m n o p q r s t u v w x y z
Neuropathy peripheral treatments and more:
- Neuropathy peripheral (130,333 reports)
COVID vaccines that are related to Neuropathy peripheral:
- Neuropathy peripheral in Moderna COVID Vaccine
- Neuropathy peripheral in Pfizer BioNTech Covid Vaccine
- Neuropathy peripheral in Johnson and Johnson Covid Vaccine
Common drugs associated with Neuropathy peripheral:
- Revlimid: 9,821 reports
- Aspirin: 5,912 reports
- Velcade: 5,091 reports
- Gabapentin: 4,842 reports
- Prednisone: 4,823 reports
- Lyrica: 4,472 reports
- Levaquin: 3,718 reports
- Zometa: 3,547 reports
- Dexamethasone: 3,249 reports
- Oxaliplatin: 3,205 reports
All the drugs that are associated with Neuropathy peripheral:
- Neuropathy peripheral (2,666 drugs)
Common conditions associated with Neuropathy peripheral:
- Multiple myeloma: 14,933 reports
- Pain: 3,261 reports
- Rheumatoid arthritis: 3,138 reports
- High blood pressure: 2,949 reports
- High blood cholesterol: 2,396 reports
- Breast cancer: 2,183 reports
- Multiple sclerosis: 2,176 reports
- Ovarian cancer: 1,928 reports
- Depression: 1,914 reports
All the conditions that are associated with Neuropathy peripheral:
- Neuropathy peripheral (1,960 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on doxorubicin hydrochloride (the active ingredients of Doxil) and Doxil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zolpidem Tartrate and Musculoskeletal Chest Pain - now
- Sulfadiazine and Renal Tubular Disorder - a second ago
- Glucotrol and Amidate drug interaction - 2 seconds ago
- Modafinil and Mitral Valve Stenosis - 6 seconds ago
- Cortisone Acetate and Nabumetone drug interaction - 11 seconds ago
- Vitamin D3 and Oxaydo drug interaction - 11 seconds ago
- Ranitidine and Skin Swelling - 12 seconds ago
- Aubagio and Vitiligo - 13 seconds ago
- Amaryl and Type 1 Diabetes - 18 seconds ago
- Yaz and Vitamin C drug interaction - 19 seconds ago